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Background: In degenerative intervertebral discs (IVDs) collagen type X expression and calciﬁcations have
been demonstrated, resembling advanced osteoarthritis (OA), which is associated with hypertrophic
differentiation, characterized by the production of collagen type X, Runt-related transcription factor 2
(Runx2), osteoprotegerin (OPG), alkaline phosphatase (ALP) and calciﬁcations.
Objective: The aim of this study was to determine if hypertrophic differentiation occurs during IVD
degeneration.
Methods: IVDs from all Thompson degeneration grades were prepared for histology, extraction of nucleus
pulposus (NP) and annulus ﬁbrosis (AF) tissue (N¼ 50) and micro-CT (N¼ 27). The presence of collagen
type X, OPG and Runx2 was determined by immunohistochemistry, with OPG levels also determined by
Enzyme-linked immunosorbent assay (ELISA). The presence of calciﬁcation was determined by micro-CT,
von Kossa and Alizarin Red staining.
Results: Immunohistochemical staining for collagen type X, OPG, Runx2 appeared more intense in the NP
of degenerative compared to healthy IVD samples. OPG levels correlated signiﬁcantly with degeneration
grade (NP: P< 0.000; AF: P¼ 0.002) and the number of microscopic calciﬁcations (NP: P¼ 0.002; AF:
P¼ 0.008). The extent of calciﬁcations on micro-CT also correlated with degeneration grade (NP:
P< 0.001, AF: P¼ 0.001) as did von Kossa staining (NP: P¼ 0.015, AF: P¼ 0.016). ALP staining was only
incidentally seen in the transition zone of grades IV and V degenerated IVDs.
Conclusion: This study for the ﬁrst time demonstrates that hypertrophic differentiation occurs during IVD
degeneration, as shown by an increase in OPG levels, the presence of ALP activity, increased immuno-
positivity of Runx2 and collagen type X.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Chronic low back pain is a common health problem in indus-
trialized countries with high medical, insurance and disability
costs1. Intervertebral disc (IVD) degeneration is considered to be
a major cause of this disorder2.
The IVD is a cartilaginous structure consisting of a gel-like core,
the nucleus pulposus (NP), which is surrounded by a ﬁbrous ring,L.B. Creemers, Department of
eidelberglaan 100, 3584 CX
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H.J. Rutges), l.b.creemers@
bility for the integrity of the
s Research Society International. Pthe annulus ﬁbrosis (AF)2,3. Although articular cartilage (AC) and
the IVD morphologically appear to be very different structures,
there are quite some similarities at the biochemical level3. Themain
constituents of the extracellular matrix (ECM) of the NP and AC are
collagen type II and aggrecan. Additionally, both articular and
meniscal cartilage and the IVD are essentially avascular tissues and
nutrients mainly reach the cells by diffusion4. On the other hand,
also clear differences are found, including a higher proteoglycan to
collagen ratio in the NP compared to AC and differential expression
levels of several proteins2,5e7.
The similarities between AC and the IVD are not only limited to
their physiology, but also include the pathological processes
accompanying their degeneration. In both osteoarthritis (OA) and
IVD degeneration, collagen II and aggrecan are degraded by several
matrix degrading enzymes, including several matrix metal-
loproteinases (MMPs) and a disintegrin andmetalloproteinasewithublished by Elsevier Ltd. All rights reserved.
Table I
Patient characteristics. A: Number of samples, gender and age for histology,
immunohistochemistry and biochemistry per Thompson degeneration grade.
B: Number of samples, gender and age for Micro-CT analysis per Thompson
degeneration grade
Thompson grade N Gender Mean age (years) Range
M F
A
I 10 4 6 17.7 3.3e34.2
II 10 7 3 45.7 17.0e69.3
III 10 6 4 62.3 46.9e76.4
IV 10 3 7 73.2 54.3e88.5
V 10 4 6 76.6 59.5e88.2
Total 50 24 26 55.1 3.3e88.5
B
I 5 1 4 12.7 3.3e21.8
II 5 4 1 41.7 17.0e60.0
III 7 6 1 71.0 56.0e78.9
IV 6 4 2 63.0 23.8e79.8
V 4 1 3 75.9 57.4e90.8
Total 27 16 11 53.7 3.3e90.8
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rowed joint/disc height, subchondral sclerosis and osteophytes are
found. Moreover, the histological changes found in OA are similar to
those found in the degenerating IVDs, with an increase in ﬁbrous
tissue, clefts and chondroid nests5.
Advanced stages of OA are accompanied by hypertrophic
differentiation, a process characterized by the induction of collagen
type X, alkaline phosphatase (ALP) and eventually matrix
calciﬁcation11,12.
Runt-related transcription factor 2 (Runx2), a transcription
factor essential in osteoblast differentiation and bone formation, is
clearly upregulated during hypertrophic differentiation and is
thought to be involved in the progression of OA13,14. Most of
Runx2’s downstream targets are found to be increased in OA,
including collagen X, osteoprotegerin (OPG) and ALP. OPG is
a glycoprotein that is secreted by osteoblastic cells and is a potent
inhibitor of osteoclast differentiation and activation15,16. Increased
levels of OPG have been found in osteoarthritic cartilage and more
recently in synovial ﬂuid and serum from patients with OA17,18. ALP
is known to be involved in ECMmineralization during hypertrophic
differentiation and endochondral ossiﬁcation and is produced in OA
chondrocytes12,19,20. Ultimately, hypertrophic differentiation in
chondrocytes leads to matrix calciﬁcation, as seen in end stage OA
and during endochondral ossiﬁcation12,21.
Despite the similarities found in the biochemistry of IVD
degeneration and OA, only circumstantial data are available on the
possible occurrence of hypertrophic differentiation in disc degen-
eration. Previous reports have described the presence of type X,
MMP-13 and calciﬁcations of the ECM in degenerative discs22e26.
Also the presence of Runx2 and OPG has been found in degenerated
or herniated human IVDs. However, these studies involved a small
number of IVDs, without healthy grade I discs for comparison and
thus could not deﬁnitively pinpoint a possible association between
degeneration and the production of Runx2 and OPG27,28. ALP has
until now only been described in a rabbit model of IVD
degeneration29.
Therefore the aim of this study is to determine the extent to
which markers of hypertrophic differentiation are present in
degenerative IVDs and whether calciﬁcation is associated with
degeneration, by studying these processes in a collection of human
IVDs of all degeneration stages.
Materials and methods
Reagents and antibodies
Rabbit polyclonal antibody anti-human Runx2 (SC-10758) was
obtained from Santa Cruz biotechnology, (Santa Cruz, USA). Mouse
monoclonal antibody anti-human OPG (MAB8051) was purchased
from R&D systems (Minneapolis, USA). The mouse monoclonal
antibody anti-human collagen type X, was a kind gift fromDr. Kwan
(Cardiff University, Cardiff, Wales, United Kingdom)26. Mouse and
rabbit isotype controls and polyclonal goat anti-rabbit/HRP (P0449)
and polyclonal goat anti-mouse immunoglobulins/HRP (P0447)
were purchased from Dako (Glostrup, Denmark). ALP activity was
detected by a fuchsin substrate-chromogen system (K0624, DAKO,
Glostrup Denmark). The recombinant protein, the capture and
detection antibody for the OPG Enzyme-linked immunosorbent
assay (ELISA) were all obtained from R&D Systems (Minneapolis,
USA, 185-OS, MAB8051 and BAF805 respectively).
Sample acquisition
The study was approved by the medical ethical committee of the
University Medical Center Utrecht and the scientiﬁc committee fromthe Department of Pathology of the UMC Utrecht. Human IVD tissue
wasobtainedaspartof the standardpostmortemprocedure, inwhich
a section of the lumbar and thoracic spine is removed for diagnostic
purposes. Samples were obtained within 38 h after death of the
patient (92% of the patients within 24 h). Between death and time of
tissue collection, the deceased patients were kept at the mortuary at
4C. In a previous study, it was shown that in tissue obtained by this
procedure, activation of matrix degrading enzymes was not affected
by a postmortem delay of up to 24 h9. From all patients, the IVD from
the fourth and ﬁfth lumbar vertebrae (L4eL5), including the adjacent
endplates, was obtained. One grade I disc from a 25-year-old patient
was not obtained at autopsy but from schwannoma resection.
The grade of degeneration was macroscopically scored according
Thompson et al. by three individual observers (JR, RD and LC)30.
After individual scoring the score was averaged; outliers, i.e., more
than one Thompson grade difference, were re-evaluated by the three
observers at a consensus meeting (Table I).
Localization of OPG, Runx2 and collagen type X by
immunohistochemistry
Immunohistochemical staining was performed on decalciﬁed
parafﬁn sections. Peroxidase activity was blocked with 0.3% H2O2 in
methanol for 10 min at room temperature (RT). Antigen retrieval
was performed by pronase (0.1%, Roche) and hyaluronidase (1%,
Sigma) in phosphate buffered saline (PBS) at 37C for 30 min.
A block step with PBS/bovine serum albumin (BSA) 5% was used for
the OPG and collagen type X staining. In Runx2 staining blocking
with 1% egg white in PBS for 15 min at RT was followed by incu-
bation with 5% skim milk in phosphate buffered saline with 0.1%
Tween (PBS-T) for 10 min at 4C.
Incubation with primary antibodies for OPG (5 mg/ml), Runx2
(0.2 mg/ml) and collagen type X (30 mg/ml) in PBS/BSA 5% was done
overnight at 4C. The secondary antibody in PBS/BSA 5% (5 mg/ml)
was incubated for 1 h at RT followed by incubation with DAB.
Sections were counterstained with Mayer’s hematoxylin. Negative
controls were incubated with isotype controls at the same IgG
concentration as the primary antibody.
Protein extraction
Macroscopically, IVD tissue was divided into NP and AF. In one
grade I (surgical sample) as well as in one grade V patient only NP
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identiﬁed. Tissues were embedded in Tissue Tek and from each NP
or AF sample, 100 sections (7 mm) were cut with a cryomicrotome.
Sections were collected, weighed after removal of the Tissue Tek
and lysed in 0.5% sodium deoxycholate, 0.1% Triton X-100, 0.1% SDS
and complete protease inhibitor cocktail (Roche, Mannheim
Germany). Samples were gently mixed overnight at 4C, followed
by 15 min centrifugation at 16,000g at 4C after which the super-
natant was collected and stored at 20C.
Quantiﬁcation of OPG levels by ELISA
Human OPG levels were detected by multiplex ELISA.
Recombinant OPG was reconstituted to a concentration of 5 mg/ml.
Calibration curves from recombinant protein standards were
prepared using two-fold dilution steps in serum diluents. 10 ml
containing 1000 capture antibody-coupled microspheres (antibody
coupling concentration 200 mg/ml) was added to the standard,
sample or blank, and incubated for 60 min. Next, 10 ml of bio-
tinylated detection antibodies (0.5 ug/ul) was added to each well
and incubated for an additional 60 min. Beads were washed with
1% BSA, 0.5% Tween 20 in PBS pH 7.4. After incubation for 10 min
with 50 ng / well streptavidin R-phycoerythrin (BD Biosciences, San
Diego CA, USA) and washing twice with 1% BSA, 0.5% Tween 20 in
PBS pH 7.4, the ﬂuorescence intensity of the beads was measured in
a ﬁnal volume of 100 ml High Performance ELISA-buffer (Sanquin,
Amsterdam, the Netherlands). Measurements and data analysis
were performed using the Bio-Plex system in combinationwith the
Bio-Plex Manager software version 3.0 using ﬁve parametric curve
ﬁtting (Bio-Rad Laboratories, Hercules CA, USA). OPG levels were
corrected to the wet weight lysed protein per sample.
Micro-CT experiments
Midsagittal IVD slices (2e4 mm thick) were scanned using
a micro-computed tomography (micro-CT) scanner (Skyscan 1076,
Skyscan, Kontich, Belgium). A scan of 180 degrees was made at
a voltage of 60 kV and a current of 167 mA using a 0.5 aluminum
ﬁlter and an exposure time of 4.4 seconds. Three-dimensional
reconstructions were made using NRecon (NRecon software
version 1.5, Skyscan, Belgium). Reconstructions were semi-quan-
titatively scored by two independent observers (JR and MR). In the
endplate (EP), NP and AF multiple calciﬁcations were graded þþ,
two clear calciﬁcations þ, one single calciﬁcation  and no calci-
ﬁcations were graded . Scores were analyzed and differences
between the observers were re-evaluated during a consensus
meeting.
Histology: von Kossa, alizarin red, ALP and combined staining of
NADH dehydrogenase, von Kossa and eosin
Von Kossa and alizarin red staining were performed on non-
decalciﬁed parafﬁn sections. For the von Kossa staining, the
sections were placed in 1% silver nitrate under UV light for 20 min,
washed in 5% sodium thiosulfate for 5 min and counterstained with
Mayer’s hematoxylin31. For alizarin red staining, sections were
stained for 2 min in 2% alizarin red S, pH 4.0, and counterstained
with Mayer’s hematoxylin32. Blinded sections were graded by two
independent observers (JR and RD). In the EP, NP and AF, intensive
calciﬁcations throughout the entire region were graded þþ, two
clear calciﬁcationsþ, one single calciﬁcation and no calciﬁcations
were graded . The transition zone between the AF and the NP was
scored as part of the NP, since the border between the transition
zone and the AF was more easily determined than between the NP
and the transition zone. Differences between the observers werere-evaluated during a consensus meeting. For 9% of the sections,
more than one grade difference in calciﬁcation score between the
observers was noted. For these sections an experienced pathologist
(JK) independently scored the calciﬁcation grade. The ALP staining
and the combined staining of nicotinamide adenine dinucleotide
hydron (NADH) dehydrogenase with von Kossa and eosin were
performed on frozen sections. The fuchsine substrate-chromogen
system was used for staining of ALP activity according to the
manufacturer’s instructions. A combined NADH von Kossa staining
was used to verify that calciﬁcations occurred around viable cells as
indicated by positive NADH staining, to exclude possible aspeciﬁc
calciﬁcation by cell death. Sections were incubated in 0.1% NADH in
nitro blue tetrazolium solution, ﬁxed in 10% formalin, followed by
von Kossa staining and eosin staining.
Statistical analysis
Statistical analysis was performed with SPSS 16.0 software.
Spearman’s non-parametric test was used for correlation analyses.
Differences between degeneration grades were analyzed by
KruskaleWallis non-parametric one-way analysis of variance fol-
lowed by non-parametric multiple comparison test and Bonferroni
correction.
Results
Immunohistochemistry of Runx2, collagen type X and OPG
In non-degenerative discs, no staining for Runx2 was observed.
A predominantly nuclear staining in both the NP and AFwas seen in
degenerative discs [Fig. 1(A) and 1(B)]. Striking was the staining in
the transition zone between the NP and the AF [Fig.1(B)], as early as
in grade III discs. In more degenerative IVDs, grades IV and V, Runx2
was also found in the NP and AF of the IVD.
Collagen type X staining was found in the cytoplasm and the
territorial matrix surrounding cells in the NP of degenerative discs
from grades II to V. The matrix surrounding chondrocyte clusters in
severely degenerated discs also showed a positive staining [Fig. 1
(D)]. This pattern, albeit apparently less intense, was also seen in
the inner rim of the AF [Fig. 1(E)]. In non-degenerative discs, some
staining of NP cells was observed, however this seemed far less
than in degenerative discs [Fig. 1(F)]. Collagen type X staining of
cells or matrix of the AF was not seen in non-degenerative discs.
Immunohistochemical staining for OPG showed a cytoplasmic
and ECM staining in the NP and transition zone between NP and AF
in degenerative IVDs [Fig. 1(G) and 1(H)]. This staining pattern
seemed less intense in the AF. More ECM staining was observed
near clefts and the transition zone between the AF and the vertebral
body. In non-degenerative discs some positive cells were seen,
however this seemed clearly less than in degenerative IVDs and no
ECM staining was found [Fig. 1(I)].
OPG levels quantiﬁed by ELISA
Quantitative analysis of OPG showed a positive correlation
between degeneration grade and OPG levels for both the NP and
AF; (CC 0.563, P< 0.001 and CC 0.430, P¼ 0.002 respectively).
Signiﬁcant differences in NP OPG levels were found between
several degeneration grades; (grades I vs III P¼ 0.02, grades I vs IV
P¼ 0.03 and grades I vs V P¼ 0.002) (Fig. 2).
A signiﬁcant positive correlation between microscopic calciﬁ-
cations shown by the von Kossa staining and OPG levels was found
both in the NP and AF, CC 0.420, P¼ 0.002 and CC 0.380, P¼ 0.008
respectively. No difference was found between OPG levels in NP
and AF.
Fig. 1. Immunohistochemical staining of Runx2 (AeC), collagen type X (DeF) and OPG (GeI). Runx2 staining in (A); the NP of a Thompson grade IV IVD, in (B); the transition zone
from NP to AF of a Thompson grade IV IVD and (C); in a Thompson grade III non-degenerative IVD. Staining for collagen type X in (D); the NP of a Thompson grade V IVD, (E); the
transition zone from NP to AF of a Thompson grade V IVD and (F); in a non-degenerative Thompson grade III IVD. Staining for OPG in (G); the NP of a Thompson grade IV IVD, (H);
the transition zone from NP to AF of a Thompson grade V IVD and (I); in a non-degenerative grade I IVD. Scale bars indicate 100 mm in A and B, 500 mm in C and D, 200 mm in E and
50 mm in FeI.
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Calciﬁcations were found in both the AF and the NP of degener-
ative IVDs, especially near tears and clefts (Fig. 3). The extent of
calciﬁcations on micro-CT correlated signiﬁcantly to degeneration
grade for both theNP and theAF, (correlation coefﬁcient (CC): 0.580,
P¼ 0.002 and CC: 0.670, P< 0.001 respectively) (Table II).Fig. 2. OPG levels for NP and AF per degeneration grade and age group. *¼ P< 0.05
and **¼ P< 0.005. Error bars indicate the 95% conﬁdence intervals.The youngest patient in which calciﬁcations in the AF were
observed was 17 years old (Thompson grade II). The youngest
patient in which calciﬁcations in the NP were found was 56 years
old (Thompson grade III).Histology: von Kossa, alizarin red, ALP and combined staining of
NADH dehydrogenase, von Kossa and eosin
Microscopic calciﬁcations were demonstrated by alizarin red and
von Kossa staining in the NP and AF of both non-degenerative and
degenerative IVDs. No calciﬁcations were found in the cartilage end-
plate of degenerative en non-degenerative discs. In non-degenerative
discs, calciﬁcations were found in the NP around remaining noto-
chordal cells (age until 21 years) and the areas where these cells
probably had beenpresent earlier on [Fig. 4(E) and 4(F)]; histologically,
notochordal cells are easily recognized as large irregularly shaped cells
containing vesicle-like structures, usually organized in cell clusters33.
In a recent publication on fetal IVD development, these were further
characterized by immunopositivity for endothelial membrane antigen
(EMA) and pan cytokeratin (AE1/AE3)34. After the notochordal cells
are gone, the remaining ECM is characterized by the presence of large
cell remnants still containing some vesicle-like structures. In degen-
erative discs, the calciﬁcations were mainly found near clefts in the
discs and in the transition zonebetweenNPandAF [Fig. 4(A) and4(B)].
No signiﬁcant correlation was found between alizarin red
staining and degeneration grade. In contrast, a clear statistically
signiﬁcant positive correlation was found between the extent of
Fig. 3. A: Micro-CT image of a Thompson grade I IVD. B: Micro-CT image of a Thompson grade IV IVD with calciﬁcation in both the AF (arrows) and NP (arrowheads).
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degeneration grade (CC: 0.342, P¼ 0.015 and CC: 0.344, P¼ 0.016
respectively) (Tables III and IV).
Staining of NADH dehydrogenase showed viable cells
throughout the entire IVD of both non-degenerated and degen-
erated discs, and few non-viable cells were seen. In combination
with the von Kossa staining, calciﬁcations were found in the areas
directly surrounding viable cells, indicating the calciﬁcations were
not a result of cell death12,35, but most likely involved in an active
process [Fig. 4(D)]. However, ALP activity was incidentally seen in
a limited number of cells and sections of severely degenerated
(Thompson grades IV and V) discs in the transition zone from NP to
AF [Fig. 4(C)].Discussion
This study clearly shows that hypertrophic differentiation
occurs during IVD degeneration, with a concomitant increase in
calciﬁcation. As the primary aim was to demonstrate hypertrophy
in degenerated IVDs, extensive histological analysis was employed
to yield mainly qualitative data on the presence of hypertrophic
markers. Positive collagen type X staining was found both in the NP
and AF of degenerative IVDs. Positive staining for OPG and Runx2
was found in the NP, AF and transition zone of degenerative IVDs
and OPG levels correlated with degeneration grade in both the NP
and AF. An increase in calciﬁcations in the IVD was seen by micro-
CT and histology in both the NP and AF of the degenerative IVD.
Calciﬁcations demonstrated by micro-CT were predominantly
found in the transition zone and AF, while by von Kossa and alizarin
red staining, calciﬁcations were also seen in the NP. NADH staining
showed that these calciﬁcations were not a result of cell death. OPG
levels also correlated with the extent of macroscopic calciﬁcations
in the NP and AF shown by the von Kossa staining. However, only
a limited number of ALP-positive cells were found, restricted to the
transition zone between the NP and AF of degenerative IVDs.Table II











 100% 100% 86% 67% 25%
 0% 0% 14% 0% 0%
þ 0% 0% 0% 33% 25%
þþ 0% 0% 0% 0% 50%
AF
 100% 60% 57% 17% 0%
 0% 40% 29% 50% 50%
þ 0% 0% 14% 0% 25%
þþ 0% 0% 0% 33% 25%
þþ: multiple intense calciﬁcations,þ: two or more clear calciﬁcations,: one single
calciﬁcation, : no calciﬁcations.Recently the presence of Runx2 mRNAwas reported in a murine
model for IVD degeneration and in a limited number of IVD samples
from patients with degenerative disc disease27. In the murine
model Runx2 protein was demonstrated in the endplate of
degenerated discs, but in human IVDs, Runx2 protein has not been
analyzed before27. From the current study, it appears that Runx2 is
clearly produced by the NP and AF cells of degenerated IVDs. How
Runx2 expression is induced during the degeneration of cartilagi-
nous tissues is currently unknown14. Runx2 expression could be
induced by the loss of proteoglycans and hyaluronic acid, as Runx2
expression was recently found to be inhibited by hyaluronic acid36.
Additionally the increase in Runx2 production could also be caused
by altered mechanical loading in degenerative discs, since Runx2 is
known to be a mechanoresponsive transcription factor37.
As in OA, Runx2 during IVD degeneration may regulate the
expression of genes that characterize the hypertrophic and osteo-
blastic phenotype, for example collagen type X. An increase in the
production of collagen type X in degenerative discs compared to
non-degenerative discs has been described previously, although
some staining in the NP of non-degenerative discs was always
observed24e26.
The current study clearly shows increased OPG levels in
degenerative IVDs compared to healthy discs. Similar ﬁndings are
reported in a recent immunohistochemical study which describes
the presence of OPG in a porcine model for IVD degeneration and
one herniated human IVD28. The positive cytoplasmic staining of
OPG in degenerative discs indicates that OPG is produced by NP
and AF cells, however, the ECM staining near the clefts could
indicate that OPG here was partially derived from diffusion into
the degenerative disc from the adjacent vertebrae. Especially in
grade V degenerative discs, the endplate is completely disrupted
and therefore OPG produced by the osteoblasts in the vertebrae
could easily have diffused through the clefts to the IVD. It is
currently unknown how OPG expression is regulated in the IVD,
but similarly to OPG expression by osteoblasts, it may be
regulated by Runx2 produced by the NP and AF cells38,39. As to
the role of OPG in IVD degeneration, as in OA, OPG may be
chondroprotective40.
A signiﬁcant correlation between calciﬁcations in the IVD and
degeneration grade was found, largely in accordance with the
results of other studies22,23,41, although no difference in the extent
of calciﬁcations in the NP and AF was found, in contrast to
a previous report41. This difference could be caused by the fact
that we were able to detect smaller sized calciﬁcations in the NP
with micro-CT than is possible by X-ray analysis. Still, not all
calciﬁcations found by von Kossa and alizarin red staining in
grades II and III discs were detected by micro-CT. This is most
likely due to the resolution of micro-CT. Whereas small calciﬁca-
tions on a histological section can easily be visualized by
increasing the magniﬁcation, small calciﬁcations on a micro-CT
image appear as 1 or 2 darker pixels, which are not recognizable
as calciﬁcations. Large calciﬁcations were more easily detected by
Fig. 4. A and B: Large calciﬁcation in the AF from a Thompson grade IV IVD stained with alizarin red (A) and von Kossa (black/brown B). C: ALP activity (red staining) in the
transition zone of the NP and AF of a Thompson grade IV IVD. D: Combined staining of NADH dehydrogenase (blue), von Kossa (black/brown) and eosin (pink) in Thompson grade V
IVD. E: Calciﬁcation stained with alizarin red near notochordal cells (arrow) in the NP of a 3.3-year-old child. F: Calciﬁcation stained with von Kossa (black/brown) near notochordal
cells (arrow) in the NP of a 3.3-year-old child. Scale bars indicate 500 mm (A, B), 100 mm (C, F) 50 mm (D) and 200 mm (E).
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micro-CT scoring and only one section per sample was analyzed
for histological scoring.Table III












 44% 40% 40% 10% 20%
 33% 30% 10% 30% 10%
þ 22% 30% 50% 60% 50%
þþ 0% 0% 0% 0% 20%
AF
 88% 50% 50% 50% 40%
 11% 20% 20% 20% 10%
þ 0% 30% 30% 30% 50%
þþ 0% 0% 0% 0% 0%
þþ: multiple intense calciﬁcations,þ: two or more clear calciﬁcations,: one single
calciﬁcation, : no calciﬁcations.Calciﬁcations of the IVD have been described previously in
degenerative discs from older patients, but also in young
patients22,23,42. In the latter group (0e20 years), calciﬁcations areTable IV












 44% 30% 30% 0% 30%
 33% 40% 10% 30% 0%
þ 22% 30% 60% 60% 50%
þþ 0% 0% 0% 10% 20%
AF
 89% 40% 40% 50% 20%
 0% 30% 30% 10% 10%
þ 11% 30% 30% 40% 50%
þþ 0% 0% 0% 0% 20%
þþ: multiple intense calciﬁcations,þ: two or more clear calciﬁcations,: one single
calciﬁcation, : no calciﬁcations.
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to degeneration42,43. In older patients, disc calciﬁcations are mainly
found in the cervical and lumbar spine42. In the current study,
microscopic calciﬁcations were also found both in degenerative and
non-degenerative IVDs. Calcium salts stained by von Kossa were
found around viable cells, indicating that at least some of the
calciﬁcations are produced by viable cells. The calciﬁcations
produced by these cells could be the result of end stage hypertro-
phic differentiation. In young, non-degenerative discs, microscopic
calciﬁcations were mainly found in the NP and were always asso-
ciated with notochordal cells or the remnants of these cells, indi-
cating a different underlying mechanism. Also the size of
calciﬁcations found in non-degenerative discs seemed smaller than
in the degenerated discs. The absence of Runx2, OPG and ALP
activity in non-degenerated IVDs with calciﬁcation indicate that
these calciﬁcations are most likely not caused by end stage hyper-
trophic differentiation. Hypertrophic differentiation is ﬁnally
accompanied by an increase in ALP activity and mineralization. The
ALP activity found in the current study was located in the transition
zone between the NP and AF, in a limited number of cells in
degenerative IVDs. Limited ALP activity was described in a rabbit
model of IVD degeneration, although from this study a relationwith
degeneration could not be inferred29. Our ﬁndings suggest that ALP
is also involved in ECM mineralization during IVD degeneration,
especially since the localization of ALP activity coincided with the
location where many of the calciﬁcations were found, i.e., the
transition zone. However, there is a clear discrepancy between
the high extent of calciﬁcation found in the degenerative IVD and
the relatively low number of ALP-positive cells. Moreover, the
chondroid nests in the IVD sections were negative, in contrast to
the ALP positivity characteristic for chondrocyte clones in OA. These
discrepancies may be partly explained by the difference in detec-
tion methods, In the current study, active ALP was visualized with
a substrate-chromogen system, whereas in other studies immu-
nohistochemical staining was used to visualize ALP-positive
chondrocytes19,44. As ALP is sensitive to ﬁxation, this may have
partially reduced ALP activity to below enzymatic detection levels
in areas with relatively low activity compared to the transition
zone45. As for articular chondrocytes46. ALP activity in the IVD may
be regulated by Runx2.
Why hypertrophic differentiation is most prominent in the
transition zone is not clear, but may be related to local biome-
chanical loading proﬁles. As hydrostatic pressure inhibits ossiﬁca-
tion, whereas tensile strains stimulate this, in the transition zone,
which is relatively low in PGs and thus will experience less
hydrostatic pressure, the balance may be tipped earlier towards
ossiﬁcation47.
In contrast to the NP and AF, calciﬁcations in the cartilage endplate
were not observed. The endplate calciﬁcation reported in previous
studies, measured by conventional radiology or micro-CT, usually
denotes the thickening of the subchondral bone underlying the
cartilaginousendplate, rather thancalciﬁcationof the endplateproper.
Until now, calciﬁcation in the human IVD endplate as local calcium
deposits has never been shown, only variations in calcium concen-
tration of endplate tissue digests26. Thinning of the endplate has also
been termed calciﬁcation, but this parameter is difﬁcult to quantify48.
The apparently increased immunopositivity of Runx2, collagen
type X, OPG and presence of ALP in the current study suggest that
the process of hypertrophic differentiation also occurs in and is part
of the process of IVD degeneration. Calciﬁcation in advanced stages
of IVD degeneration could be a ﬁnal result of the ongoing hyper-
trophic differentiation. Further empirical studies are needed to
deﬁne the role of hypertrophy in IVD degeneration and the possi-
bility to interfere with these processes in order to prevent or slow
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